GlaxoSmithKline Pharmaceuticals Ltd reported an 18% revenue increase to ₹946 crore for Q3 ended December 31, 2024, with a ...

India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.

India's Intellectual Property Appellate Board (IPAB) has revoked the patent for global pharmaceutical company, GlaxoSmithKline's anti-cancer drug Tykerb. Tykerb (lapatinib) is a dual tyrosine ...

GlaxoSmithKline Pharmaceuticals Ltd. (‘GSK India’) announces completion of its transaction with Novartis Healthcare Pvt. Ltd. ... GSK Pharma's Bengaluru facility to be operational by 2017 The ...

GSK has announced a 50/50 joint venture with ... six-in-one combination paediatric vaccine to help protect children in India and other developing countries from polio and other infectious diseases.

New Delhi, Mar 3 () Drug firm GlaxoSmithKline Pharmaceuticals on Tuesday said it has appointed Sridhar Venkatesh as managing director & vice president of GSK India, effective April 1, 2020.

GlaxoSmithKline Pharma Ltd announced its Q3 results today posting a solid jump in its net profit. Consolidated PAT for the ...

Abbott India posts Q2 profit rise on strong demand, price hikes November 7, 2024 India's GlaxoSmithKline Pharmaceuticals reported a higher second-quarter adjusted profit on Tuesday, driven by ...